Topical Corticosteroid Potency and Selection

Introduction to Topical Corticosteroids

Topical corticosteroids are classified into 7 potency categories, ranging from ultra-high potency (class 1) to low potency (classes 6 and 7), with specific brand names available for each strength level, as recommended by the American Academy of Dermatology 1, 2

Ultra-high potency (Class 1) corticosteroids include Dermovate (clobetasol propionate 0.05%) and Ultravate (halobetasol propionate 0.05%), as classified by the American Academy of Dermatology 1, 3
High potency (Class 2) corticosteroids include Diprolene (betamethasone dipropionate 0.05%) and Topicort (desoximetasone 0.25%), as recommended by the American Academy of Dermatology 2
Mid-strength (Class 4) corticosteroids include Eumovate (clobetasone butyrate 0.05%) and Synalar (fluocinolone acetonide 0.025%), as classified by the American Academy of Dermatology 2, 3

Ultra-high potency (Class 1) corticosteroids are recommended for thick, chronic plaques of psoriasis, as suggested by the American Academy of Dermatology 1, 2
High potency (Class 2) corticosteroids are recommended for moderate to severe plaque psoriasis, as recommended by the American Academy of Dermatology 1, 2
Mid-potency (Classes 3-5) corticosteroids are recommended for moderate psoriasis and as initial therapy for most adults, as suggested by the American Academy of Dermatology 2
Low potency (Classes 6-7) corticosteroids are recommended for face, intertriginous areas, and children, as recommended by the American Academy of Dermatology and the British Association of Dermatologists 2, 4

For scalp application, 15-30g of topical corticosteroid is recommended for a two-week period, as suggested by the American Academy of Dermatology and the National Institute for Health and Care Excellence 3, 5
For face and neck, 15-30g of topical corticosteroid is recommended for a two-week period, as suggested by the American Academy of Dermatology and the National Institute for Health and Care Excellence 3, 5

Efficacy rates of topical corticosteroids vary from 41% to 92%, with higher potency corticosteroids generally showing greater efficacy, as reported by the American Academy of Dermatology 1
The risk of adverse effects increases with prolonged use, higher potency, occlusion, and application to areas with thinner skin, as warned by the American Academy of Dermatology 1
Limiting the duration of ultra-high potency corticosteroids to 2-4 weeks is recommended, as suggested by the American Academy of Dermatology 1
Intermittent treatment is recommended for long-term management to minimize side effects, as suggested by the American Academy of Dermatology 1
Consider rotational or combination strategies with non-steroidal agents to maintain efficacy while reducing side effects, as recommended by the American Academy of Dermatology 6

Short-term use of betamethasone valerate 0.1% cream for 2-3 weeks is recommended for acute flares, as advised by the American Academy of Dermatology 7, 8
After the initial treatment period, gradual tapering is advised rather than abrupt discontinuation to prevent rebound flares, according to the Journal of the American Academy of Dermatology 9
For chronic eczema, consider intermittent "weekend therapy" (twice weekly application) as maintenance to prevent relapses after achieving control, as recommended by the American Academy of Dermatology 10

Betamethasone valerate 0.1% cream is classified as a potent (Class 3) topical corticosteroid, with efficacy rates ranging from 68-72% in clinical trials, as reported by the American Academy of Dermatology 7, 11

Avoid prolonged continuous use beyond 2-3 weeks due to increased risk of local side effects such as skin atrophy, as warned by the American Academy of Dermatology 9, 10
Monitor for signs of skin thinning, telangiectasia, and striae, as advised by the American Academy of Dermatology 9

Always use betamethasone valerate 0.1% cream with regular emollients (applied at different times) to enhance efficacy and reduce steroid requirements, as recommended by the American Academy of Dermatology 8, 10
Apply after bathing when possible, as slightly damp skin may enhance absorption, according to the American Academy of Dermatology 10
Use creams for weeping/acute eczema and ointments for dry/chronic eczema, as suggested by the American Academy of Dermatology 7
Tachyphylaxis (decreased efficacy with continued use) may occur with prolonged continuous use, supporting the case for intermittent application schedules, as reported by the American Academy of Dermatology 9